Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Oct 15 8:40 PM | ERIC DUBE | Proposed Sale | 243,735 | $53.27 | $13.0M | — | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Sale | 112,850 | $63.33 | $7.1M | 98,197(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Sale | 96,198 | $62.25 | $6.0M | 98,197(D) | View → |
| Sep 17, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 8,282 | $65.07 | $538.9K | 117,066(D) | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 172,717 | $63.43 | $11.0M | 117,066(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Sale | 102,190 | $62.26 | $6.4M | 117,066(D) | View → |
| Sep 15, 2026 | Sep 18 1:33 AM | Jula InrigEVP, Head of R&D & CMO | Sale | 44,674 | $62.34 | $2.8M | 100,491(D) | View → |
| Sep 15, 2026 | Sep 18 1:32 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 37,500 | $62.34 | $2.3M | 105,389(D) | View → |
| Sep 17, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 108,493 | $64.61 | $7.0M | 432,886(D) | View → |
| Sep 16, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 195,841 | $63.45 | $12.4M | 432,886(D) | View → |
| Sep 15, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 95,666 | $62.26 | $6.0M | 432,886(D) | View → |
| Sep 15, 2026 | Sep 18 1:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 50,508 | $62.34 | $3.1M | 87,508(D) | View → |
| Sep 15, 2026 | Sep 18 1:29 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 5,375 | $62.33 | $335.0K | 42,353(D) | View → |
| Sep 17, 2026 | Sep 17 8:35 PM | ERIC DUBE | Proposed Sale | 108,493 | $63.48 | $6.9M | — | View → |
| Sep 17, 2026 | Sep 17 8:30 PM | PETER HEERMA | Proposed Sale | 8,282 | $63.48 | $525.7K | — | View → |
| Sep 16, 2026 | Sep 16 8:33 PM | WILLIAM ROTE | Proposed Sale | 112,850 | $62.51 | $7.1M | — | View → |
| Sep 16, 2026 | Sep 16 8:32 PM | PETER HEERMA | Proposed Sale | 172,717 | $62.51 | $10.8M | — | View → |
| Sep 16, 2026 | Sep 16 8:30 PM | ERIC DUBE | Proposed Sale | 195,841 | $62.51 | $12.2M | — | View → |
| Sep 15, 2026 | Sep 15 8:44 PM | SANDRA CALVIN | Proposed Sale | 5,375 | $65.79 | $353.6K | — | View → |
| Sep 15, 2026 | Sep 15 8:44 PM | CHRISTOPHER CLINE | Proposed Sale | 50,508 | $65.79 | $3.3M | — | View → |
Page 1 of 10
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |